Xenoestrogens may be the cause of high and increasing rates of hormone receptor positive breast cancer in the world.

[1]  G. Colditz,et al.  Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer , 2007, Nature Clinical Practice Oncology.

[2]  S. Calderwood,et al.  Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  K. Knudsen,et al.  Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis , 2006, Breast Cancer Research and Treatment.

[4]  D. M. Parkin,et al.  Use of Statistics to Assess the Global Burden of Breast Cancer , 2006, The breast journal.

[5]  Zhao Chen,et al.  Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.

[6]  A. Neugut,et al.  Improving Organochlorine Biomarker Models for Cancer Research , 2005, Cancer Epidemiology Biomarkers & Prevention.

[7]  F. Clavel-Chapelon,et al.  Progestins and progesterone in hormone replacement therapy and the risk of breast cancer , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  P. Sismondi,et al.  Breast cancer and sex steroids: Critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer , 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[9]  C. Finnerty,et al.  Signaling from the membrane via membrane estrogen receptor-α: Estrogens, xenoestrogens, and phytoestrogens , 2005, Steroids.

[10]  E. Deych,et al.  Predictors of organochlorines in New York City pregnant women, 1998-2001. , 2005, Environmental research.

[11]  C. Watson,et al.  Xenoestrogens at Picomolar to Nanomolar Concentrations Trigger Membrane Estrogen Receptor-α–Mediated Ca2+ Fluxes and Prolactin Release in GH3/B6 Pituitary Tumor Cells , 2005, Environmental health perspectives.

[12]  P. Boyle,et al.  Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. , 2004, American journal of epidemiology.

[13]  M. García-Closas,et al.  Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  C. Charlier,et al.  Polychlorinated biphenyls contamination in women with breast cancer. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[15]  A. Sasco,et al.  Breast Cancer Risk and the Combined Effect of Environmental Estrogens , 2004, Cancer Causes & Control.

[16]  S. Sell,et al.  Stem cell origin of cancer and differentiation therapy. , 2004, Critical reviews in oncology/hematology.

[17]  G. Dontu,et al.  Breast cancer, stem/progenitor cells and the estrogen receptor , 2004, Trends in Endocrinology & Metabolism.

[18]  Y. Coyle.  The Effect of Environment on Breast Cancer Risk , 2004, Breast Cancer Research and Treatment.

[19]  D. Bonofiglio,et al.  Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor α , 2004, Food additives and contaminants.

[20]  M. Citron,et al.  Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  Alan Ashworth,et al.  Stem cells and breast cancer: A field in transit , 2003, Nature Reviews Cancer.

[22]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[23]  J. Marx.  Mutant Stem Cells May Seed Cancer , 2003, Science.

[24]  R. Rudel,et al.  Environmental pollutants and breast cancer. , 2003, Environmental health perspectives.

[25]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  F. Olea-Serrano,et al.  Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cells , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  K. Malone,et al.  Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  G. S. Pope,et al.  Oestrogenic activity of parabens in MCF7 human breast cancer cells , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[30]  A. Miller,et al.  Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada) , 2001, Cancer Causes & Control.

[31]  G. Berglund,et al.  Smoking associated with hormone receptor negative breast cancer , 2001, International journal of cancer.

[32]  Larissa B. Thackray,et al.  Apoptosis in normal and neoplastic mammary gland development , 2001, Microscopy research and technique.

[33]  A K Gill,et al.  Hormone receptor status of breast cancer in India: a study of 798 tumours. , 2000, Breast.

[34]  E. Özer,et al.  Oestrogen receptor alpha in female fetal, infant, and child mammary tissue , 2000 .

[35]  R C Millikan,et al.  Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. , 2000, American journal of epidemiology.

[36]  J. Potter,et al.  The shape of age–incidence curves of female breast cancer by hormone-receptor status , 1999, Cancer Causes & Control.

[37]  Jacques Ferlay,et al.  Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.

[38]  C. Weinberg,et al.  Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability. , 1998, American journal of epidemiology.

[39]  D. Zava,et al.  Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. , 1997, Environmental health perspectives.

[40]  C. Dees,et al.  DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle , 1997, Molecular carcinogenesis.

[41]  R. Repetto,et al.  Pesticides and the immune system: the public health risks. Executive summary. , 1996, Central European journal of public health.

[42]  B. Madhukar,et al.  Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. , 1996, Cancer research.

[43]  R. Rudel,et al.  Mapping out a search for environmental causes of breast cancer. , 1996, Public health reports.

[44]  J Benichou,et al.  Proportion of breast cancer cases in the United States explained by well-established risk factors. , 1995, Journal of the National Cancer Institute.

[45]  H. Adami,et al.  Organochlorine compounds and estrogen-related cancers in women , 1995, Cancer Causes & Control.

[46]  M. Moses.  Designer Poisons: How to Protect Your Health and Home from Toxic Pesticides , 1995 .

[47]  C. Sonnenschein,et al.  The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. , 1994, Environmental health perspectives.

[48]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[49]  R. Verreault,et al.  High organochlorine body burden in women with estrogen receptor-positive breast cancer. , 1994, Journal of the National Cancer Institute.

[50]  C. Sonnenschein,et al.  p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. , 1991, Environmental health perspectives.

[51]  M. Loeffler,et al.  Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. , 1990, Development.

[52]  R. Sylvester,et al.  Relation between estrogen receptor concentration and clinical and histological factors: their relative prognostic importance after radical mastectomy for primary breast cancer. , 1989, European journal of cancer & clinical oncology.

[53]  G. Stancel,et al.  DDT supports the growth of an estrogen-responsive tumor. , 1985, Toxicology letters.

[54]  S. Spear.  Surgery of the Breast: Principles and Art , 2006 .

[55]  S. Bartow.  Use of the Autopsy to Study Ontogeny and Expression of the Estrogen Receptor Gene in Human Breast , 2004, Journal of Mammary Gland Biology and Neoplasia.

[56]  G. S. Pope,et al.  Oestrogenic activity of benzylparaben , 2003, Journal of applied toxicology : JAT.

[57]  K. Malone,et al.  Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  N. Chatterjee,et al.  Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  A. Miller,et al.  Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[60]  D. Parkin.  The global burden of cancer. , 1998, Seminars in cancer biology.

[61]  H. Adami,et al.  Towards an understanding of breast cancer etiology. , 1998, Seminars in cancer biology.

[62]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.